Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 24Breast Neoplasms 22Multiple Myeloma 11Neoplasm Metastasis 9Pain 8Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Bone Neoplasms 5Osteoporosis 4Fractures, Bone 4Bone Diseases 4Lung Neoplasms 3Bone Diseases, Metabolic 3Spinal Cord Compression 2Humoral Hypercalcemia Of Malignancy 2Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Pleural Effusion, Malignant 1Paraproteinemias 1Neoplastic Processes 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Lymphoma 1Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1Hematologic Neoplasms 1Hematologic Diseases 1Disease Progression 1Carcinoma, Renal Cell 1

Interventions

Zoledronic Acid 2Denosumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Spinal Cord Compression × Zoledronic Acid × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT00330759 2022-11-07

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Amgen

Phase 3 Completed
1,779 enrolled 14 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Spinal Cord Compression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡